Compass Therapeutics developing proprietary antibody therapeutics to treat both solid tumors and hematologic malignancies.
For more details on financing and valuation for Compass Therapeutics, register or login.
By registering, you agree to Forge’s Terms of Use. Already registered? Log in
CMPX
3.15 as of 3/28/23
To read this article and more news on Compass Therapeutics, register or login.